Showing 361-370 of 4007 results for "".
What’s New in Topical Acne Treatment?
https://practicaldermatology.com/topics/acne-rosacea/whats-new-in-topical-acne-treatment/23277/Can Prescription Hyperhidrosis Treatments Help Mitigate Symptoms?
https://practicaldermatology.com/issues/novemberdecember-2025/can-prescription-hyperhidrosis-treatments-help-mitigate-symptoms/48890/Clinicians should begin to think beyond standard protocols and recognize sweat management as a potentially powerful tool in their therapeutic arsenal.Can Prescription Hyperhidrosis Treatments Help Mitigate Symptoms?
https://practicaldermatology.com/topics/rare-disease/can-prescription-hyperhidrosis-treatments-help-mitigate-symptoms/39997/Update on Pediatric Psoriasis
https://practicaldermatology.com/columns/clinical-focus-1/update-on-pediatric-psoriasis/23358/New guidelines and new treatments seek to dramatically improve lives of children with psoriasis.The Impact of Socioeconomic Status in Atopic Dermatitis and How the Internet Can Act as a Public Health Intervention
https://practicaldermatology.com/youngmd-connect/resident-resource-center/the-impact-of-socioeconomic-status-in-atopic-dermatitis-and-how-the-internet-can-act-as-a-public-health-intervention/23326/CBD in the Holistic Practice of Dermatology
https://practicaldermatology.com/topics/psoriasis/cbd-in-the-holistic-practice-of-dermatology/23319/A growing body evidence suggests CBD may help with common symptoms of dermatologic diseases. Here’s what we know so far.Complications of Biologic Therapy for Psoriasis: Part II
https://practicaldermatology.com/topics/psoriasis/complications-of-biologic-therapy-for-psoriasis-part-ii/22039/Therapeutic success requires clinicians to understand emerging and established safety concerns.How Epidermolysis Bullosa Treatments Went from Blisters to Breakthroughs
https://practicaldermatology.com/topics/rare-disease/how-epidermolysis-bullosa-treatments-went-from-blisters-to-breakthroughs/54391/Current FDA-approved therapies oleogel-S10, beremagene geperpavec, and prademagene zamikeracel represent major therapeutic breakthroughs for the treatment of epidermolysis bullosa (EB). Earlier systemic intervention, improved nutrition, and proactive management of complications have extended survivMoisturizers for Skin Diseases: New Insights
https://practicaldermatology.com/topics/atopic-dermatitis/moisturizers-for-skin-diseases-new-insights/22977/Exploring Patient-Reported Outcomes Measures in Atopic Dermatitis
https://practicaldermatology.com/topics/atopic-dermatitis/exploring-patient-reported-outcomes-measures-in-atopic-dermatitis/23886/Patient-reported outcomes may solve some of the challenges with measuring the physical and psychosocial manifestations.